Disease/Infection News

RSS

Furiex initiates MuDelta Phase III studies in IBS-D

Furiex Pharmaceuticals, Inc. today announced dosing of the first patient in its Phase III randomized, double-blind, placebo-controlled studies evaluating efficacy, safety and tolerability of MuDelta (JNJ-27018966) in the treatment of diarrhea-predominant irritable bowel syndrome (IBS-D).

20 Jun 2012

New, comprehensive approach to treating underserved South Florida patients living with HIV/AIDS

Ushering in a new, comprehensive approach to treating underserved South Florida patients living with HIV/AIDS, the University of Miami Miller School of Medicine has announced a partnership with Magic Johnson Enterprises and Clear Health Alliance, a Medicaid specialty plan offered by Simply Healthcare Plans, a minority owned and operated managed care plan.

19 Jun 2012

Gilead's elvitegravir MAA for HIV-1 infection receives EMA validation

Gilead Sciences, Inc. announced today that its Marketing Authorisation Application (MAA) for elvitegravir, an integrase inhibitor for the treatment of HIV-1 infection in treatment-experienced patients, has been validated by the European Medicines Agency (EMA).

19 Jun 2012

Skin disease shares common inflammatory pathway with metabolic disorder

Psoriasis is an independent risk for Type 2 Diabetes, according to a new study by researchers with the Perelman School of Medicine at the University of Pennsylvania, with the greatest risk seen in patients with severe psoriasis.

19 Jun 2012

Next-generation sequencing technologies for the 1,000 Rare Diseases Project

BGI, the world's largest genomics organization, and The Children's Hospital of Philadelphia (CHOP) today announced that they have jointly initiated the 1,000 Rare Diseases Project with the aim of accelerating the discovery of genetic variants underlying rare diseases.

19 Jun 2012

Commensal bacteria essential to fight off viral infections

Healthy humans harbor an enormous and diverse group of bacteria and other bugs that live within their intestines. These microbial partners provide beneficial aid in multiple ways - from helping digest food to the development of a healthy immune system.

19 Jun 2012

New clues to why some urinary tract infections recur persistently

Scientists at Washington University School of Medicine in St. Louis have found new clues to why some urinary tract infections recur persistently after multiple rounds of treatment.

19 Jun 2012

AOAC certifies InstantLabs Salmonella Species Food Safety Kit

InstantLabs Medical Diagnostics Corporation, developer of the portable Hunter Accelerated Real-Time PCR system, today announced that its Salmonella Species Food Safety Kit has been certified as AOAC Performance-Tested (AOAC PTM Cert. No. 031202) by the AOAC Research Institute (AOAC-RI) across four key food matrices.

19 Jun 2012

iBio expands iBioModulator portfolio with allowance of patent for anthrax vaccines

iBio, Inc. today announced that the US Patent Office has allowed patent application 11/706,576 entitled "Bacillus anthracis Antigens, Vaccine Compositions, and Related Methods."

19 Jun 2012

T2Endotoxin assay extends reach of T2MR detection

T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the presentation of data on endotoxin detection at the American Society for Microbiology General Meeting, June 16-19, 2012, in San Francisco, CA.

18 Jun 2012

Henry Schein Medical to distribute Alma Lasers' nail fungus treatment

Alma Lasers, Inc. has announced an exclusive distribution arrangement with Henry Schein Medical to launch its latest innovation Harmony ClearChoice – a new, fast, effective approach to nail restoration.

18 Jun 2012

Tips to avoid becoming a mosquito meal

Summer has barely begun but it's likely many people have already encountered one of the season's most ubiquitous pests - the mosquito. As is the case with many other insects, mosquitoes have made an early emergence after a mild winter and rainy spring. The National Pest Management Association (NPMA) warns that this might be one of the worst seasons yet, so break out the repellant.

18 Jun 2012

New solution to detect DNA base modifications associated with epigenetic regulation and DNA damage

Pacific Biosciences of California, Inc., today launched a new and unique solution to detect DNA base modifications associated with epigenetic regulation and DNA damage using the PacBio RS High Resolution Genetic Analyzer.

18 Jun 2012

Wellcome Trust awards University of Maryland $4M to accelerate development of conjugate NTS vaccine

The University of Maryland School of Medicine's Center for Vaccine Development (CVD) has received a $4 million Strategic Translation Award from the prestigious Wellcome Trust to support a collaboration with Bharat Biotech for clinical development of a new conjugate vaccine to prevent the potentially lethal infectious disease caused by invasive non-typhoidal Salmonella.

18 Jun 2012

First study to look at hotel room cleanliness

An experiment of surfaces in hotel rooms finds television remotes to be among the most heavily contaminated with bacteria and items on housekeeping carts carry the potential to cross-contaminate rooms. Researchers from the University of Houston report the findings today at the 2012 General Meeting of the American Society for Microbiology.

18 Jun 2012

Greater Than AIDS, Walgreens partner to mark National HIV Testing Day

Walgreens, the nation's largest pharmacy chain, and Greater Than AIDS, a coalition of public and private sector partners united in response to the domestic epidemic, are teaming with health departments and local AIDS organizations to provide FREE HIV testing at 47 Walgreens stores in 20 cities across the nation in June in support of National HIV Testing Day.

18 Jun 2012

AIDS Institute proposes increases for AIDS medications and level funding for prevention

"The AIDS Institute thanks Chairman Tom Harkin for his leadership in maintaining the United States Senate's strong commitment to domestic HIV programs by increasing funding for the AIDS Drug Assistance Program (ADAP) and maintaining funding for HIV prevention and other parts of the Ryan White HIV/AIDS Program," commented Carl Schmid, Deputy Executive Director of The AIDS Institute.

16 Jun 2012

Methodist receives $26.2M H&HS grant to reduce blood infections and delirium

Grants from the U.S. Department of Health & Human Services totaling $26.2 million will support work by The Methodist Hospital in Houston to reduce blood infections and delirium-caused injuries in Texas hospitals.

16 Jun 2012

Governments, private sector partners come together at Child Survival Call to Action in Washington

The two-day Child Survival Call to Action, "a conference hosted by the government in collaboration with Ethiopia, India and UNICEF to recognize and promote efforts to curtail child mortality," began in Washington, D.C., on Thursday, the Associated Press/Washington Post reports, noting that U.S. Secretary of State Hillary Clinton and actor Ben Affleck, founder of the Eastern Congo Initiative, "were two of more than 80 governmental, civil society and business leaders slated to speak at the conference Thursday and Friday."

16 Jun 2012

Large-scale trial of vaginal ring that releases anti-HIV drug announced at health summit in London

"This week, at the Pacific Health Summit in London, the final large-scale trial was officially launched of a vaginal ring which women can wear and forget about -- at least for a month at a time -- while it releases an HIV virus-killing drug called dapivirine," the Guardian reports.

16 Jun 2012